Literature DB >> 24263311

Predictive factors for the benefit of perioperative FOLFOX for resectable liver metastasis in colorectal cancer patients (EORTC Intergroup Trial 40983).

Lilian Schwarz1, Pierre Michel, Michel Scotté.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 24263311     DOI： 10.1097/SLA.0000000000000419

Source DB:  PubMed          Journal:  Ann Surg        ISSN： 0003-4932            Impact factor:   12.969


× No keyword cloud information.
  3 in total

1.  Computed tomograpy evaluation of morphological changes, clinical response and survival in colorectal cancer liver metastasis treated by regorafenib: A case report.

Authors:  Nobuhisa Matsuhashi; Takao Takahashi; Junko Kato; Toshiyuki Tanahashi; Satoshi Matsui; Yoshiyuki Sasaki; Hisashi Imai; Yoshihiro Tanaka; Naoki Okumura; Kazuya Yamaguchi; Manabu Futamura; Shinji Osada; Kazuhiro Yoshida
Journal:  Mol Clin Oncol       Date:  2016-10-05

Review 2.  Management of oligometastatic rectal cancer: is liver first?

Authors:  Timur Mitin; C Kristian Enestvedt; Charles R Thomas
Journal:  J Gastrointest Oncol       Date:  2015-04

3.  Preoperative lymphocyte-to-monocyte ratio represents a superior predictor compared with neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios for colorectal liver-only metastases survival.

Authors:  Jianhong Peng; Hui Li; Qingjian Ou; Junzhong Lin; Xiaojun Wu; Zhenhai Lu; Yunfei Yuan; Desen Wan; Yujing Fang; Zhizhong Pan
Journal:  Onco Targets Ther       Date:  2017-07-27       Impact factor: 4.147
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.